Literature DB >> 6990090

Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency.

M Schambelan, A Sebastian, E G Biglieri.   

Abstract

Our findings indicate that hypoaldosteronism occurs commonly (23/31 patients) in hyperkalemic patients with chronic renal insufficiency and that the deficiency of aldosterone contributes to the pathogenesis of the hyperkalemia. In most patients (83%), hypoaldosteronism could be accounted for by deficient renal secretion of renin, but in some patients (17%) overt renin deficiency did not appear to be present, and therefore other (unidentified) causes of aldosterone deficiency must be invoked. The results also indicate that the urinary excretion rate of aldosterone secretion rate in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6990090     DOI: 10.1038/ki.1980.11

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Pathogenesis, diagnosis and management of hyperkalemia.

Authors:  Anja Lehnhardt; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

2.  Safety of perioperative hemodialysis and continuous hemodiafiltration for dialysis patients with cardiac surgery.

Authors:  Keiji Kamohara; Masaru Yoshikai; Junji Yunoki; Hideyuki Fumoto; Junichi Murayama; Masakatsu Hamada; Tsuyoshi Itoh
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-02

3.  Reversible impairment of renal function associated with enalapril in a diabetic patient.

Authors:  M M Albareda; R Corcoy
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

4.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

Review 5.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

6.  Hyporeninemic hypoaldosteronism complicating primary autonomic insufficiency.

Authors:  F I Polsky; D Roque; P E Hill
Journal:  West J Med       Date:  1993-08

7.  Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.

Authors:  B D Kirby; J Ham; H B Fairley; N Benowitz; M Schambelan
Journal:  West J Med       Date:  1983-08

Review 8.  Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management.

Authors:  André Gustavo P Sousa; João Victor de Sousa Cabral; William Batah El-Feghaly; Luísa Silva de Sousa; Adriana Bezerra Nunes
Journal:  World J Diabetes       Date:  2016-03-10

9.  A Bedouin kindred with infantile nephronophthisis demonstrates linkage to chromosome 9 by homozygosity mapping.

Authors:  N B Haider; R Carmi; H Shalev; V C Sheffield; D Landau
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

Review 10.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.